Purchase Order 75N92025P00353

Award Date 9/3/25
Potential Completion Date 9/2/26
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for Task Order 19 under a broader Delivery Order contract with Ozgene PTY LTD, an Australian company providing genetically modified mice and related services in support of biomedical research. The $67,700.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract provides for services such as...
This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...
This federal contract award is for the provision of live animals, specifically genetically modified mice, to support biomedical research. The prime contractor, Ozgene PTY LTD, an Australian company, is providing gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to various agencies within the U.S. Department of Health and Human Service's National Institutes of Health (NIH). The contract, with a ceiling value of $5,971.00, is a firm fixed-price...
This is a federal contract award to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $1,504.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is for Ozgene to maintain a small colony of mice for a 12-week period, including mating wild-type and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract, valued at $5,940.00, was awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract is for the delivery of MICE, with no set-aside designation. Ozgene PTY LTD, as the...
This federal contract award is for HHSN272200900005I|HHSN27200027, a Delivery Order issued to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' (HHS) National Institutes of Health (NIH), and has a ceiling value of $70,800.00. The contract scope includes the...
This is a delivery order worth $2,244 awarded to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), and did not utilize a set-aside designation. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $56,300.00 firm fixed-price delivery order is for services including gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst injection,...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...

This federal contract award is for a mouse colony breeding service to support an ongoing project involving transgenic hemoglobin mice at Ozgene, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, and has a ceiling value of $21,267.00 under a firm fixed price purchase order. The contract has an ultimate completion date of September 2, 2026. No set-aside designation was used for this award.

Generated 9/9/25, 12:57 PM